Current Therapeutic Research

期刊简介：We also encourage the submission of manuscripts presenting preclinical and very preliminary research that may stimulate further investigation of potentially relevant findings, as well as in-depth review articles on specific therapies or disease states, and applied health delivery or pharmacoeconomics.CTR encourages and supports the submission of manuscripts describing:• Interventions designed to understand or improve human health, disease treatment or disease prevention;• Studies that focus on problems that are uncommon in resource-rich countries;• Research that is "under-published" because of limited access to monetary resources such as English language support and Open Access fees (CTR offers deeply discounted English language editing);• Republication of articles previously published in non-English journals (eg, evidence-based guidelines) which could be useful if translated into English;• Preclinical and clinical product development studies that are not pursued for further investigation based upon early phase results.

【译文】我们也鼓励提交那些可能激发进一步研究潜在相关发现的临床前和非常初步研究的稿件，以及关于特定疗法或疾病状态的深入综述文章，以及应用健康交付或药物经济学方面的文章。CTR 鼓励并支持提交以下内容的稿件：•旨在理解或改善人类健康、疾病治疗或疾病预防的干预措施；•关注在资源丰富国家中不常见的问题的研究；•由于有限的货币资源访问，如英语语言支持和开放获取费用（CTR 提供深度折扣的英语语言编辑）而未发表的研究；•在非英语期刊（例如，循证指南）上发表的文章的再版，如果翻译成英语可能有用；•基于早期阶段结果而没有进一步研究的产品开发研究。